β-And α-Thalassemia intermedia in Basra, Southern Iraq

Hemoglobin

Volumn 37, Issue 6, 2013, Pages 553-563

  Abdulwahid, Dhurgham A ^a   Hassan, Mea'Ad K ^b  

^a Basra Maternity and Children Hospital ^*  (Iraq)

^b UNIVERSITY OF BASRAH   (Iraq)

Author keywords

Thalassemia intermedia ( TI); Thalassemia intermedia ( TI); Basra; Hb H ( 4); Southern Iraq

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; HEMOGLOBIN H; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; BODY MASS; BONE DENSITOMETRY; CHILD; CHOLECYSTECTOMY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DENSITOMETRY; ERYTHROCYTE; EXTRAMEDULLARY HEMATOPOIESIS; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GALLSTONE; GROWTH RETARDATION; HEART FAILURE; HEMATOPOIESIS; HUMAN; HYPERTENSION; IRAQ; IRON OVERLOAD; JAUNDICE; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OSTEOPOROSIS; PALLOR; PRESCHOOL CHILD; PULMONARY HYPERTENSION; RISK FACTOR; SCHOOL CHILD; SEXUAL MATURATION; SHORT STATURE; SKIN ULCER; THALASSEMIA INTERMEDIA;

ADOLESCENT; ADULT; ALPHA-THALASSEMIA; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; ERYTHROCYTE INDICES; FEMALE; HEMOGLOBINS; HUMANS; INFANT; IRAQ; IRON OVERLOAD; MALE; MIDDLE AGED; PHENOTYPE; SPLENECTOMY; YOUNG ADULT;

EID: 84887228366     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.825841     Document Type: Article

References (34)

1. Giardina PJV, Forget BG. Thalassemia syndromes. In: Hoffman R, Shattil SJ, Furie B, Silberstein LE, McGlave P, Eds. Hoffman Hematology: Basic Principles and Practice, 5th ed. Philadelphia: Churchill Livingstone. 2008:606-632.
2. Modell B, Darlison M. Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ. 200886(6):480-487.
3. Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Med Health J. 2010;16 (4):381-385.
4. Yahya HI, Khalel KJ, Al-Allawi NA, Helmi F. Thalassaemia genes in Baghdad, Iraq. East Med Health J. 1996;2(2):315-319.
5. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Med Health J. 2003;1(2):1-9.
6. Adams RJ, Brambilla D. Genetic disorders of hemoglobin. In: Hoffbrand AV, Moss PA, Pettit IE, Eds. Essential Hematology, 5th ed. Malden: Blackwell Publishing Company. 2006:72-84.
7. David J. Hemoglobin and the inherited disorders of globin synthesis. In: Hoffbrand AV, Catovsky D, Tuddenham EG, Eds. Postgraduate Hematology, 5th ed. Malden: Blackwell Publishing Company. 2005:85-89.
8. Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematal Educ Program. 2009:26-34.
9. Taher A, Musallam KM, Cappellini MD. Optimal management of thalassaemia intermedia. Br J Haematol. 2011;152(5):512-523.
10. Camaschella C, Cappellini MD. Thalassemia Intermedia. Haematologica. 1995;80(158-68.
11. Rachmilewitz EA, Giardina PJV. How I treat thalassemia Blood. 2011;118(13):3479-3488.
12. National Center for Health Statistics Centers for Disease Control (CDC). PedNSS Health Indicators. 2009. http://www.cdc.gov/pednss/what-is/pednss-health- indicators.html (accessed February 7 2012.)
13. Krebs NF, Primak LE. Obesity. In: Kliegman RM, Jenson HB, Marcdante KJ, Behrman RE, Eds. Nelson Essentials of Pediatrics, 5th ed. Philadelphia: Elsevier Saunders. 2006:140-142.
14. Kushner RF. Evaluation and management of obesity. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Eds. Harrison's Principles of Internal Medicine, 17th ed. New York: McGraw-Hill Companies. 2007:468-472.
15. Taher A, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115(111886-1893.
16. Cappellini MD, Musallam KM, Taher A. Thalassemia Intermedia an update. Mediterr J Hematol Infect Dis. 2009;1(1625-31.
17. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 2002;285 (26):1441-1446.
18. Cappellini MD, Musallam KM, Cesaretti C, Taher A. Thalassemia intermedia. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, Eds. Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism. Genoa: Forum Service Editore. 2009:286-309.
19. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 200810(142.
20. Fattoum S. Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect. Mediterr J Hemat Infect Dis. 2009;1(1e2009005.
21. Hamamy H, Al-Hait S, Alwan A, Ajlouni K. Jordan: communities and community genetics. Community Genet. 2007;10(152-60.
22. Hamamy H. Consanguineous marriages; preconception consultation in primary health care settings. J Community Genet. 2012;3(3):185-192.
23. Alwan A, Modell B. Community control of genetic and congenital disorders. World Health Organization. Eastern Mediterranean Regional Office Technical Publication, Series 24. 1997:64-66.
24. www.consang.net/global prevalence. Accessed January 6 2013.
25. Ankra-Badu GA, Al-Jama A, Al Kadim Y. HemoglobinH disease in the AL-Qatif region of Saudi Arabia. Ann Saudi Med. 2001;21(5-6):308-311.
26. Qadri MI, Islam SA. HemoglobinHdisease in the eastern region of Saudi Arabia. Saudi Med J. 2000;21 (7):666-671.
27. Venugopal S, Dhuri S, Al Jabal KB, Shaju A. Hemoglobin H disease in Muscat, Oman-A 5 year study. Oman Med J. 200823(2):82-85.
28. Karamifar H, Karimi M, Amirhakimi GH, Badiei M. Endocrine function in thalassemia intermedia. Int J Biomed Sci. 2006;2(3):236-340.
29. Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791-800.
30. Laosombat V, Viprakasit V, Chotsampancharoen T, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88(12):1185-1192.
31. Cappellini MD, Robbiolo L, Bottasso BM, Beuzard Y. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111(2):467-473.
32. Taher AT, Musallam KM, El-Beshlawy A, et al. Age-related complications in treatment-naïve patients with thalassaemia intermedia. Br J Haematol. 2010;150(4):480-497.
33. Vichinsky E. Complexity of thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann NY Acad Sci. 2010;1202:180-187.
34. Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia. Haematologica. 2006;91(3):e37-e38.